Cogent Biosciences Inc [COGT] stock is trading at $9.31, down -3.22%. An important factor to consider is whether the stock is rising or falling in short-term value. The COGT shares have gain 11.50% over the last week, with a monthly amount glided 20.75%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cogent Biosciences Inc [NASDAQ: COGT] stock has seen the most recent analyst activity on December 11, 2024, when Needham downgraded its rating to a Hold. Previously, Robert W. Baird downgraded its rating to Neutral on February 26, 2024, and dropped its price target to $8. On February 08, 2024, Citigroup initiated with a Buy rating and assigned a price target of $11 on the stock. Wedbush downgraded its rating to a Neutral but stick to its price target of $5 on December 11, 2023. JP Morgan initiated its recommendation with a Overweight and recommended $18 as its price target on December 08, 2023. Robert W. Baird started tracking with a Outperform rating for this stock on April 28, 2023, and assigned it a price target of $20.
Cogent Biosciences Inc [COGT] stock has fluctuated between $4.30 and $12.61 over the past year. Currently, Wall Street analysts expect the stock to reach $14.5 within the next 12 months. Cogent Biosciences Inc [NASDAQ: COGT] shares were valued at $9.31 at the most recent close of the market. An investor can expect a potential return of 55.75% based on the average COGT price forecast.
Analyzing the COGT fundamentals
Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -46.61%, Pretax Profit Margin comes in at -43.36%, and Net Profit Margin reading is -43.36%. To continue investigating profitability, this company’s Return on Assets is posted at -0.63, Equity is -0.71 and Total Capital is -0.79. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.94 points at the first support level, and at 8.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.74, and for the 2nd resistance point, it is at 10.16.
Ratios To Look Out For
For context, Cogent Biosciences Inc’s Current Ratio is 6.44. On the other hand, the Quick Ratio is 6.44, and the Cash Ratio is 1.83.
Transactions by insiders
Recent insider trading involved Pinnow Cole, Chief Commercial Officer, that happened on Jan 14 ’25 when 43750.0 shares were purchased.
